111 related articles for article (PubMed ID: 12393833)
1. Sirolimus-eluting coronary stents.
Sharma S; Bhambi B; Nyitray W
N Engl J Med; 2002 Oct; 347(16):1285; author reply 1285. PubMed ID: 12393833
[No Abstract] [Full Text] [Related]
2. The dollars and sense of drug-eluting stents.
Brophy JM
CMAJ; 2005 Feb; 172(3):361-2. PubMed ID: 15684119
[No Abstract] [Full Text] [Related]
3. The impact of Sirolimus Eluting stents in interventional cardiology.
Di Mario C; Griffiths H; O'Rourke B; Kaddoura S
Int J Cardiol; 2004 Jun; 95(2-3):117-21. PubMed ID: 15193808
[No Abstract] [Full Text] [Related]
4. Drug-eluting stents: the panacea for restenosis?
Lim MC
Singapore Med J; 2004 Jul; 45(7):300-2. PubMed ID: 15221043
[No Abstract] [Full Text] [Related]
5. Drug-eluting coronary stents.
Bonvini RF; Verin V
N Engl J Med; 2005 Dec; 353(22):2404-8; author reply 2404-8. PubMed ID: 16320452
[No Abstract] [Full Text] [Related]
6. Drug-eluting coronary stents.
Jneid H; Jang IK; Palacios I
N Engl J Med; 2005 Dec; 353(22):2404-8; author reply 2404-8. PubMed ID: 16320455
[No Abstract] [Full Text] [Related]
7. Drug-eluting coronary stents.
Alarcón JA; Arribas JM; Ruiz V
N Engl J Med; 2005 Dec; 353(22):2404-8; author reply 2404-8. PubMed ID: 16319393
[No Abstract] [Full Text] [Related]
8. Drug-eluting coronary stents.
Waksman R; Wolfram RM
N Engl J Med; 2005 Dec; 353(22):2404-8; author reply 2404-8. PubMed ID: 16320451
[No Abstract] [Full Text] [Related]
9. Moving beyond the cost per quality-adjusted life year: modelling the budgetary impact and clinical outcomes associated with the use of sirolimus-eluting stents.
Shrive FM; Ghali WA; Lewis S; Donaldson C; Knudtson ML; Manns BJ
Can J Cardiol; 2005 Jul; 21(9):783-7. PubMed ID: 16082437
[TBL] [Abstract][Full Text] [Related]
10. Drug-eluting coronary stents.
Czupryniak L; Pawlowski M; Loba J
N Engl J Med; 2005 Dec; 353(22):2404-8; author reply 2404-8. PubMed ID: 16320453
[No Abstract] [Full Text] [Related]
11. [Drug-eluting stents: do they keep their promises?].
Nordmann A
Praxis (Bern 1994); 2006 Apr; 95(15):581-3. PubMed ID: 16640178
[No Abstract] [Full Text] [Related]
12. Sirolimus eluting stent implantation for patients with multivessel disease: rationale for the Arterial Revascularisation Therapies Study part II (ARTS II).
Serruys PW; Lemos PA; van Hout BA;
Heart; 2004 Sep; 90(9):995-8. PubMed ID: 15310681
[No Abstract] [Full Text] [Related]
13. Percutaneous coronary intervention and drug-eluting stents.
Yang YM; Moussa I
CMAJ; 2005 Feb; 172(3):323-5. PubMed ID: 15684110
[No Abstract] [Full Text] [Related]
14. The "0%" restenosis study.
Colombo A
Ital Heart J; 2002 Oct; 3(10):559-6. PubMed ID: 12478812
[No Abstract] [Full Text] [Related]
15. Drug-eluting stents: from randomized trials to the real world.
Saia F; Degertekin M; Lemos PA; Serruys PW
Minerva Cardioangiol; 2004 Oct; 52(5):349-63. PubMed ID: 15514571
[TBL] [Abstract][Full Text] [Related]
16. Sirolimus-eluting stents: the novel application of basic science to coronary artery disease.
Foley DP
Ir Med J; 2002 Oct; 95(9):283. PubMed ID: 12470008
[No Abstract] [Full Text] [Related]
17. Biodegradable coating for drug-eluting stents--more than a facelift?
Niemelä KO
Eur Heart J; 2008 Aug; 29(16):1930-1. PubMed ID: 18586664
[No Abstract] [Full Text] [Related]
18. Towards defining the role of drug eluting stents.
Tarantini G; Ramondo A; Razzolini R
Minerva Cardioangiol; 2008 Feb; 56(1):29-34. PubMed ID: 18432166
[No Abstract] [Full Text] [Related]
19. Clinical experiences using everolimus-eluting stents in patients with coronary artery disease.
Störger H; Grube E; Hofmann M; Schwarz F; Haase J
J Interv Cardiol; 2004 Dec; 17(6):387-90. PubMed ID: 15546290
[TBL] [Abstract][Full Text] [Related]
20. The porcine coronary model of in-stent restenosis: current status in the era of drug-eluting stents.
Lowe HC; Schwartz RS; Mac Neill BD; Jang IK; Hayase M; Rogers C; Oesterle SN
Catheter Cardiovasc Interv; 2003 Dec; 60(4):515-23. PubMed ID: 14624433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
